To explore whether the intervention of ferroptosis by RSL could promote the efficiency of anti-PD-1 therapy, we analyzed the tumor growth of a subcutaneous syngeneic mouse model challenged by MC-38 cell lines. This evidence concerns the gene PDCD1 and neoplasm.